Pediatric invasive pneumococcal disease spectrum before third-generation pneumococcal conjugate vaccine implementation [0.03%]
第三代肺炎球菌结合疫苗实施前的儿童侵袭性肺炎链球菌疾病谱
Corinne Levy,Aude Estivaux,Emmanuelle Varon et al.
Corinne Levy et al.
Background: After the implementation of pneumococcal conjugate vaccines (PCVs), besides the decrease of invasive pneumococcal disease (IPD), the clinical spectrum of the remaining cases changed, with many differences amon...
Identifying infants at low risk for neonatal herpes simplex virus infection [0.03%]
识别新生儿单纯疱疹病毒感染低风险婴儿
Keerti L Dantuluri,Nathaniel S O&#x;Connell,Gang Liu et al.
Keerti L Dantuluri et al.
Background: Neonatal herpes simplex virus (HSV) infection is rare but associated with high rates of morbidity. Recent guidelines recommend considering HSV in infants < 21 days of age presenting for sepsis evaluations with...
Streptococcal serology reference intervals in an Australian pediatric cohort [0.03%]
澳大利亚儿科群体中的链球菌血清学参考区间
Shu Ki Tsoi,Sharon Choo,Lai-Yang Lee et al.
Shu Ki Tsoi et al.
Background: Diagnostic criteria for acute rheumatic fever and post-streptococcal glomerulonephritis, the two major autoimmune complications of Streptococcus pyogenes infection, include serological evidence of preceding in...
Adenovirus Species in U.S. Children with Acute Respiratory Illness, 2016-2019 [0.03%]
2016—2019年美国儿童急性呼吸道感染腺病毒病原谱变迁
Varvara Probst,Tess Stopczynski,Justin Z Amarin et al.
Varvara Probst et al.
Background: Human adenovirus (HAdV) is a common cause of pediatric acute respiratory illness (ARI). HAdV B, C, and E species have been associated with ARI, though relative detection frequencies in United States (U.S.) and...
Acute gastroenteritis among household contacts of children with severe norovirus gastroenteritis, United States, 2011-2016 [0.03%]
美国2011-2016年严重诺如病毒胃肠炎儿童的家庭接触者急性胃肠炎发生率
Mary C Moran,Mary E Wikswo,Rangaraj Selvarangan et al.
Mary C Moran et al.
Norovirus-associated AGE in children
Survey of Pediatric Infectious Diseases Providers on Healthcare Sustainability and Climate Change [0.03%]
儿科传染病提供者对医疗卫生可持续性和气候变化的调查
Shreya M Doshi,Allyson Dalby,Preeti Jaggi
Shreya M Doshi
Tuberculosis diagnosis, treatment, and prevention services for children living with HIV in low- and middle-income countries: a multiregional site survey [0.03%]
结核病患儿HIV诊断、治疗和预防服务的区域多点调查报告（低收入及中等收入国家）
Katherine Laycock,Karl-Günter Technau,Patricia Lelo et al.
Katherine Laycock et al.
Background: Tuberculosis (TB) remains a leading cause of morbidity and mortality for children living with HIV (CLHIV), with gaps in TB screening, diagnostics, management, and TB preventive therapy (TPT). We investigated r...
Improving Preparatory Materials for the Pediatric Infectious Diseases Initial Certifying Exam: A Targeted Needs Assessment [0.03%]
一项针对儿科传染病初始认证考试准备材料的缺口需求评估研究
Matthew M Sattler,Elizabeth H Ristagno,Juri Boguniewicz et al.
Matthew M Sattler et al.
We conducted a national survey of current pediatric infectious diseases (PID) fellows and PID fellowship graduates from the past ten years to assess satisfaction with existing PID initial certifying exam preparatory materials. Satisfaction ...
"Maternal Perspectives on Decision-Making for Newborn RSV Prophylaxis with Nirsevimab" [0.03%]
母亲对新生儿接受尼塞维马b预防RSV决策的看法
Sara Rizzuto Steinberg,Shetal Shah,Jasmine Cuves et al.
Sara Rizzuto Steinberg et al.
Population pharmacokinetic analysis and pharmacodynamic evaluation of sulbactam in pediatric patients: dosing suggestions for Acinetobacter baumannii infections [0.03%]
儿童患者舒巴坦药代动力学分析及药效学评估：治疗鲍曼不动杆菌感染的用药建议
Tetsushu Onita,Yui Sano,Kazuro Ikawa et al.
Tetsushu Onita et al.
Background: This study aims to develop a population pharmacokinetic (PK) model of sulbactam in pediatric patients using pooled data analysis, and to optimize dosing regimens against Acinetobacter baumannii infections. ...